Do Global Burden of Disease COVID‐19 Estimates Inflate Covid Mortality Over Mortality From the Response?
Open Access
- 16 November 2026
- journal article
- Published by Wiley in Global Policy
Abstract
Pandemic preparedness and response have become central to global health and are driving deep changes in management and resource allocation. Understanding COVID‐19's burden relative to other diseases and the impact of response interventions is therefore crucial for effective policy. The Global Burden of Disease (GBD) project has estimated 12.7 million COVID‐19 deaths within an excess mortality of 15.9 million for 2020–21, figures significantly higher than other sources. Given GBD's traditional importance for policymaking, we assessed the approach used and its likelihood of producing valid estimates. In doing so, analysis revealed that the GBD model assumes questionable higher‐than‐reported COVID‐19 mortality in populations with low vaccine uptake or low compliance with non‐pharmaceutical interventions (NPIs). GBD cites limited evidence for NPI effectiveness, counts response harms as excess mortality, and applies vaccine efficacies higher than many published reports, risking bias by inflating COVID‐19 mortality. To inform current policy changes in global policy, including proportionate and effective pandemic policy, it is critical to have a reliable understanding of the outcomes of the COVID‐19 event. The GBD's approach raises questions about the reliability of its mortality estimates and the public health response, suggesting a need for a better evidence base to inform future global health reform.This publication has 29 references indexed in Scilit:
- Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysisThe Lancet, 2023
- Physical interventions to interrupt or reduce the spread of respiratory virusesCochrane Database of Systematic Reviews, 2023
- Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory virusesCell Host & Microbe, 2023
- Age-stratified infection fatality rate of COVID-19 in the non-elderly populationEnvironmental Research, 2022
- Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021JAMA, 2022
- Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21The Lancet, 2022
- The short-term impacts of COVID-19 on households in developing countries: An overview based on a harmonized dataset of high-frequency surveysWorld Development, 2022
- Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in SwedenThe Lancet, 2022
- Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United StatesEuropean Journal of Epidemiology, 2021
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City AreaJAMA, 2020